we established a transgenic (Tg) rat carrying the human CRM1 (hCRM1) gene that encodes a 32 viral RNA transporter, which is a species-specific restriction factor. At first we found that 33 CRM1 expression is elaborately regulated through protein kinase C involving pathway during 34 lymphocyte activation initially by post-transcriptional and subsequently by transcriptional 35 manners. This fact led us to use an hCRM1 containing BAC clone, which would harbor the 36 entire regulatory and coding regions of the CRM1 gene. The Tg rats expressed hCRM1 37 protein in a manner similar to the intrinsic rat CRM1 in various organs. HTLV-1-infected T 38 cell lines derived from these Tg rats produced 100 to 10,000 fold more HTLV-1 than did T 39 cells from wild type rats, and the absolute levels of HTLV-1 were similar to those produced 40 by human T cells. We also observed enhancement of the dissemination of HTLV-1 to thymus 41 in the Tg rats after intraperitoneal inoculation, although the proviral loads were low both in 42 wild type and the Tg rats. These results support the essential role of hCRM1 in proper HTLV-43
INTRODUCTION 45 46
Human T-cell leukemia virus type I (HTLV-1) is etiologically associated with human adult 47 T-cell leukemia (ATL), a chronic progressive neurological disorder termed HTLV-1 48 associated myelopathy/tropical spastic paraparesis (HAM/TSP) (17, 27, 54, 55), and several 49 other human diseases (23, 40, 42, 48) . Examination of the viral nucleotide sequences among 50 different disease groups has not revealed any specific determinants that distinguish a 51 particular HTLV-1 associated disease (11, 35, 67) . Thus, a primary determinant of HTLV-1 52 associated disease may be host-related. 53
In order to investigate HTLV-1 infection and its related disease development in detail, 54 suitable animal models are required. HTLV-1 can immortalize simian, feline, rat, and rabbit 55 lymphocytes in vitro (2, 29, 46). HTLV-1 can also infect experimental animals, such as 56 rabbits, monkeys, and rats (2, 45, 53, 62). Using these susceptible animals, several models 57 have been developed to study HTLV-1 associated diseases. The HAM/TSP-like disease 58 model in WKA strain rats has been well established and used to dissect the pathogenic 59 mechanisms of the disease (31, 39). In contrast, only a few ATL model systems have been 60 established using rabbits and rats, but their utility is limited. For instance, the rabbit ATL 61 model shows reproducible development of an ATL-like disease in adult animals (58), but few 62 immunological studies can be performed in this animal, primarily because of the difficulty in 63 obtaining inbred strains of rabbits. In the rat models, the development of ATL-like disease 64 was observed only in newborn animals with a very short period of disease onset (64), making 65 it difficult to perform oncological and immunological studies at the same time. Kannagi and 66 Ohashi have established a rat model of ATL-like disease in which they were able to examine 67 the growth and spread of HTLV-1-infected cells, as well as assess the effects of T cells on the 68 development of the disease in T cell-deficient nude rats (51). This model system has been 69 used to assess DNA or peptide-based vaccine development (25, 52) and to study the effects of 70
Tax-directed siRNA on HTLV-1 induced tumors (50). However, since the growth of HTLV-1 71 tumors could be monitored in only immune-deficient nude rats in this model system, better 72 animal models are still necessary. 73 7 sequence and 10 kb of 3' downstream sequence, was microinjected into 450 fertilized one-160 cell eggs prepared from Fischer 344/Du Crj (F344) female rats by the YS institute. Integration 161 of the transgene was confirmed by PCR using genomic DNA, which was extracted by the 162 PUREGENE TM tissue kit (Gentra) from the rat tail, as a template with the hCRM1 specific 163 primer pairs: 5'-TTATGTGGCTGCAGTGTGGA-3' and 5'-164 ACATACCAGGGTTCTCTGGA-3', and 5'-GTCACCTGATGTCGGGAGTT-3' and 5'-165 GGATTACAGGTGTGAGCCA-3. All animal experiments were conducted according to the 166
Guide for the Care and Use of Laboratory Animals, Institute for Genetic Medicine, Hokkaido 167
University. 168
Detection of genomic copies of hCRM1 and G3PDH. Genomic DNA was subjected to 169 PCR with the following primer pairs: hCRM1, forward primer (5'-TGA GGT CAG GAG 170 TTC AGG AT-3') and reverse primer (5'-CTC TGC CTC CTG GGT TCA A-3'); G3PDH, 171 forward primer (5'-AGA GCT GAA CGG GAA G-3') and reverse primer (5'-GGA AGA 172 ATG GGA GTT GC-3'). The PCR conditions were: 5min at 94 °C, 10 cycles of 30 s at 94 173 °C, 60 s at 69 °C, with a decrease of 0.5 °C/cycle, and 30 s at 72 °C, followed by 8 cycles of 174 numbers of HTLV-1 provirus in the samples were estimated from a standard regression curve 183 using the LightCycler Software version 3 (Roche Diagnostics). The standard curve for 184 HTLV-1 provirus was obtained by PCR data using 1x10 2 to 1x10 8 copies of pCR-pX1-4 185 plasmids, which were constructed by inserting a PCR fragment amplified with pX1 (5'-CCC 186 ACT TCC CAG GGT TTG GAC AGA GTC TTC-3') and pX4 (5'-GGG GAA GGA GGG 187 GAG TCG AGG GAT AAG GAA-3') from the genomic DNA of MT-2 cells into pCR2. up to 4 h after stimulation, marked increases in the level of CRM1 protein were detected, in 253 contrast to nearly constant levels of CRM1 mRNA. Therefore, these results suggest that 254 during lymphocyte activation CRM1 production is initially stimulated post-transcriptionally 255 and then further enhanced by upregulating transcription. 256
In order to identify the signaling pathway responsible for the induction of CRM1 257 transcription, we activated PBMCs in the presence of various combinations of IL-2, calcium 258 ionophore, and PMA. As shown in Figure 1C , IL-2 and PMA fully induced CRM1 whereas 259 IL-2 and calcium ionophore did not. Next, we examined whether PMA alone is sufficient to 260 induce CRM1. PMA alone enhanced CRM1 production as efficiently as IL-2 plus PMA. 261
Since PMA is an activator of protein kinase C (PKC) (49), these data suggest that induction 262 of CRM1 is PKC dependent. 263
To confirm the above results, we examined the effect of various inhibitors including 264 staurosporine (a PKC inhibitor) (60) and cyclosporin (a Ca ++ cascade inhibitor) (66). As 265 shown in Figure 1D , staurosporine, but not cyclosporin, inhibited the induction of CRM1, 266 consistent with the results shown in Figure 1C . We further examined the effects of PDTC (an 267 NFkB inhibitor) (43) and PD98059 (a MAPKK inhibitor) (3) and found that PDTC inhibited 268 CRM1 induction at the highest dose, but PD98059 had only a minor effect. 269
Regulated expression of CRM1 in CD4 + T lymphocytes. To examine CRM1 regulation in 270
CD4
+ T lymphocytes, resting CD4 + T lymphocytes were purified by negative selection and 271 activated by treatment with a combination of IL-2, ionophore, and PMA. CRM1 levels were 272 estimated by Western blotting ( Figure. PBMCs, the amount of CRM1 mRNA also increased during CD4 + T cell activation. Although 280 the levels of CRM1 mRNA during T cell activation varied to some extent among donors, 281 similar profiles of induction were observed; after a lag of approximately 4 h, the level of 282 CRM1 mRNA started to increase and continued to do so for up to 24 h after stimulation. 283
These results suggest that the increase in CRM1 mRNA is delayed compared to the increase 284 in CRM1 protein, as seen in PBMCs. The level of CRM1 mRNA was constant at times 285 greater than 24 h post-stimulation, but purified CD4 + T cells appeared unhealthy 2 and 3 days 286 after stimulation in these cultures, as judged by microscopic observation. Therefore, further 287 examination is required to definitively determine the levels of CRM1 protein and mRNA in 288
+ T cells at later times after stimulation. 289
Expression of hCRM1 in the Tg rat. The above results indicate that regulation of CRM1 290 expression during the activation of lymphocytes is complex. Considering the lack of 291 characterization of CRM1 regulatory elements, we used a BAC clone, which is likely to 292 harbor the entire regulatory and coding regions of the CRM1 gene, to establish an hCRM1-Tg 293 rat. One rat strain carrying the hCRM1 transgene was obtained from microinjection of the 294 hCRM1 containing BAC clone into 450 fertilized one-cell eggs from F344 female rats. We 295 assessed the expression of hCRM1 protein in each tissue by immunoblotting using hCRM1 296 specific antibody (22). As shown in Figure 3A , hCRM1 expression was detected in all organs 297 tested. The expression level of this protein was especially high in ovary and thymus compared 298 to other organs. In addition, expression levels of hCRM1 in the organs were similar to those 299 of endogenous rCRM1 ( Figure 3B ). hCRM1 expression was not detected in any organs 300 prepared from wild type rats (data not shown). These data indicate that the Tg rats express 301 hCRM1 in a physiologically relevant manner. 302
Enhanced production of p19 Gag in Tg-derived cell lines. To assess the replication of 303 HTLV-1 in T cells of hCRM1 Tg rats, we established several T cell lines from both Wt and 304
Tg rats by infecting with HTLV-1. Thymocytes and splenocytes isolated from Wt or hCRM1-305
Tg rats were co-cultured with the HTLV-1-infected human T cell line MT2, which had been 306 treated with mitomycin C and then maintained in culture medium containing 10 U/ml of IL-2. 307
After 2 months of cultivation, we obtained 6 lines from Wt rats and 11 from Tg rats (Table 1) . 308
As shown in Figure 4 , all of the Tg-derived cell lines were confirmed to have the hCRM1 309 gene ( Figure 4A ) and express hCRM1 ( Figure 4B 
We next examined the expression of cell surface markers, including CD3, CD4, CD5, CD8, 313 CD25, MHC-I, and MHC-II, in these cell lines (Table 1 ). All the cell lines expressed rat 314 CD25 and MHC-I, indicating that they were derived from rat cells, not from the human MT2 315 cells. Most of the cell lines also expressed rat CD5 and MHC-II, with the exception of 2 Wt 316 and 3 Tg-derived lines. Expression of rat CD3 was confirmed in 6 of 9 Tg lines, whereas only 317 2 of 6 lines were positive in the Wt lines. Rat CD4 expression was detected in 1 Wt and 6 Tg 318 cell lines. Rat CD8 was detected in 1 Wt and 1 Tg-derived line. As judged by the expression 319 of CD3, we established a total of 8 T cell lines, 2 from Wt and 6 from Tg rats. 320
We next examined the production of the p19 Gag protein in the cell lines to assess the effect 321 of hCRM1 on HTLV-1 replication. Our results demonstrated that the Tg-derived cell lines 322 produced much greater levels of p19 in the culture supernatant, compared to the Wt-derived 323 cells ( Figure 4C ). After 2 and 4 days in culture, the mean p19 production by 9 Tg-derived cell 324 lines was 1000 ± 10 and 10000 ± 100 times higher, respectively, than the mean production of 325 the 6 Wt-derived lines ( Figure 4D ). The amounts (1-60 ng/ml) of p19 released from the Tg-326 derived cell lines are equivalent to human HTLV-1 producing T cell lines, such as MT2 and 327 MT4 (data not shown). These results clearly demonstrate the enhanced production of the 328 HTLV-1 Gag protein in the cells expressing hCRM1. 329
To further examine the increased p19 production in each cell line expressing hCRM1, we 330 conducted a FACS analysis to detect the intracellular Gag protein. As shown in Figure 4E , we 331 13 were able to detect p19 and the precursor p55 Gag protein in all cell lines derived from Tg 332 rats. In contrast, no Wt-derived cell lines produced detectable amounts of Gag. These results 333 further support the role of hCRM1 in the enhancement of HTLV-1 Gag production. 334
We also assessed the proliferation of each cell line to exclude the possibility that the 335 enhanced production was not due to increased production by individual cells, but was the 336 result of increases in the number of cells in the Tg-derived lines. As shown in Figure 4F , we 337 confirmed that there was no difference in the proliferation rate between Wt-and Tg-derived 338 cell lines after 2 or 4 days in culture. In addition, there was no correlation between the rate of 339 cell growth and the amount of p19 in the culture in any cell line. 340
The state of HTLV-1 infection is not correlated with levels of p19 production. We also 341 assessed the proviral load of each cell line to rule out the possibility that enhanced production 342 of Gag was due to increased provirus numbers in Tg cell lines. Real-time PCR analysis using 343 a pair of primers for the Tax gene was performed to quantify the number of integrated 344 provirus. As a relative standard, we used genomic DNA from FPM1 cells, which contain 3 345 copies of HTLV-1 provirus per cell (36). As shown in Figure 5A We next examined Rex expression by immunoblotting. As shown in Figure 5C infected rats over time did not show significant differences between Tg and Wt rats, although 369 the p19 concentration in Tg rats tended to be higher during the first 6 weeks after infection 370 ( Figure 6A ). Figure 6B shows the mean plasma p19 concentration in rats after 1 week of 371 infection and again demonstrates higher, but not significantly different, levels of the viral 372 protein in Tg-derived samples. To evaluate dissemination of the virus in vivo, we determined 373 the presence of HTLV-1 provirus DNA in various organs 1 week after intraperitoneal 374 infection by nested PCR that specifically amplifies a part of the px region. We calculated the 375 percentage of rats that sustained the px gene in 5 independent experiments, and found that the 376 rate with which the virus disseminated to the thymus in Tg rats was significantly higher than 377 that in Wt rats ( Figure 6C ). However, we have not detected notable differences between the 378 two groups in HTLV-1 proviral load detected in various organs including peripheral blood 379 cells and thymus ( Figure 6D Rex dimerization, which is required for RNA export from the nucleus to the cytoplasm (22) . 387
This may be one reason why HTLV-1 replicates poorly in rats compared to humans. This 388 15 observation suggests the hCRM1-Tg rats would be novel animal models, since they would 389 support better replication of HTLV-1. 390
The essential role of CRM1 in cell viability suggested that proper expression of the 391 transgene would be a key for successful construction of Tg rats. Therefore, we examined the 392 expression pattern of CRM1 and found that CRM1 is expressed in a manner similar to the 393 early response genes induced during the activation of lymphocytes, including CD4 + T cells. 394
Our results suggest that expression of CRM1 is stimulated in two steps: in the first phase, 395 lasting approximately 4 h, induction is regulated primarily in a post-transcriptional manner, 396 and in the second phase, transcriptional augmentation takes place. Alternatively, CRM1 397 protein in PBMCs may be rapidly turned over and is then protected from degradation upon 398 stimulation, giving rise to the early increase in protein levels. The profile of CRM1 399 expression further suggests that the initial induction occurs in the G 1 phase of the cell cycle, 400 which is also supported by the observation that mimosine, which blocks the cell cycle in late 401 G 1 (65), does not prevent the induction (data not shown). 402
The elaborate regulation of CRM1 expression led us to use a BAC clone harboring the entire 403 hCRM1 gene for Tg rat construction. An initial unsuccessful trial using the mouse H2 404 promoter to express hCRM1 cDNA supports the necessity of using the hCRM1 BAC. Our 405 results indicate that the hCRM1 BAC Tg rats express hCRM1 in various organs including 406 thymus and spleen, in a manner similar to endogenous rCRM1 in rats. Moreover, the 407 distribution of hCRM1 in the Tg rats is similar to that observed in humans (28, 37). Therefore, 408 use of the hCRM1 BAC construct may have resulted in physiological expression of the 409 protein in Tg rats. We also demonstrated hCRM1 expression in all Tg derived cell lines, 410 which will be useful for the functional analysis of hCRM1 in HTLV-1-infected cells. 411
We have previously reported that expression of hCRM1 induced an increase in HTLV-1 412 Gag production in both rat epithelial and T cells (21, 69). Our present study also showed that 413 The HTLV-1 Rex protein is able to functionally replace the Rev protein of HIV-1 (57). 452 CRM1 is a nuclear export factor for HIV-1 Rev and a truncated Rev mutant with weakened 453 binding affinity to CRM1 results in reduced levels of HIV-1 Gag production (20). These 454 results raise the possibility that rat cells expressing hCRM1 protein can produce enhanced 455 levels of HIV-1 structural proteins. Indeed, our preliminary results demonstrate that hCRM1 456 promotes HIV-1 p24 Gag production in rat cells (unpublished observation). Thus, the 457 hCRM1-Tg rats generated in this study may be also useful as a small animal model of HIV-1 458 infection, when HIV-1 receptors are simultaneously expressed in these rats. 459
HIV latently infects reservoirs of resting T cells (7, 9, 10, 13, 61), which are thought to be in 460 the G 0 state, and the virus is then reactivated during T cell activation. Alternatively, HIV has 461 also been reported to propagate efficiently in non-replicating lymphatic T cells (18), which 462 lack certain markers specific for activation. Since cytokines levels are high in lymphatic 463 tissues, the progression of T cells from G 0 to G 1 may support HIV replication. Although 464 release from cell cycle block has been extensively investigated at the transcriptional level, a 465 recent study has shown that the synthesis of unspliced HIV Gag RNA increases rapidly during 466 the HIV reactivation process, to a much greater extent than the synthesis of multiply spliced 467 RNAs (7). Our results demonstrating a rapid increase in CRM1 expression during lymphocyte 468 activation provide a clue to the underlying mechanism, the efficient action of the HIV Rev 469 protein, which leads to robust synthesis of unspliced RNA. We suggest that HIV gene 470 expression is regulated in lymphocytes at both the transcriptional and RNA export levels. 471
Independent of viral replication, the first phase of enhancement of CRM1 expression is also 472 coincident with the induction of cytokines, such as IL-2 (4). CRM1 interacts with the ARE 473 located in the 3' untranslated region of c-fos mRNA (via HuR and its ligands) and mediates 474 export of this mRNA from the nucleus to the cytoplasm (6, 16). Therefore, CRM1 may 475 cell line (100 ng) was subjected to PCR with the primers for hCRM1 and for G3PDH as an 759 
